Life Sciences & Pharmaceuticals

Our team helps companies establish robust auditing and monitoring programs that provide insight into the ever-evolving compliance landscape of the life sciences industry. Also, we support companies from start-ups through to those operating internationally with cross-border transactions that crystallise the need for careful tax planning.

Whether you are an emerging life sciences company bringing your first product to market or are an established company with multiple therapies, our team can help you navigate through the commercial and medical needs of your product and business.

Our market access strategy and support services help to create evidence generation plans by analyzing market intelligence and pricing strategies tailored to the needs of each funding jurisdiction.

MHA can advise on operational structures to mitigate risks by evaluating supply chain strengths, correcting weaknesses, and realigning operations to support the business’s strategic objectives.

From understanding how to claim wages, supplies and contract research costs to finding ways to increase and optimize investments in new technologies, our tax and life sciences tax specialists can help maximize the benefits of the R&D tax credits.

We provide advice across a wide range of activities including M&A advisory and business planning, transaction services and due diligence, raising capital, management advisory, business valuations and sales.

MHA’s life sciences industry specialists have a deep understanding of cross-border transactions. They collaborate closely with our tax teams to determine the most effective approach for each situation, aiming to optimise tax mitigation while ensuring compliance with transfer pricing rules and taking into account the implications of Base Erosion and Profit Shifting (BEPS).